Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I clinical trial in the Kingdom of Saudi Arabia (KSA) for a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Trial Profile

Phase I clinical trial in the Kingdom of Saudi Arabia (KSA) for a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 30 Dec 2019

At a glance

  • Drugs Middle East respiratory syndrome coronavirus vaccine - Vaccitech (Primary)
  • Indications Middle East respiratory syndrome coronavirus
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Dec 2019 New trial record
    • 20 Dec 2019 According to Vaccitech media release, Naif Alharbi, vaccinologist is Co-PI on the Saudi MERS vaccine trial.
    • 20 Dec 2019 According to Vaccitech media release, trial will take place in King Abdullah International Medical Research Center (KAIMRC) and King Abdulaziz Medical City (KAMC), both are under the Ministry of National Guard Health Affairs (Saudi NGHA)

Trial Overview

Purpose

Phase I clinical trial in the Kingdom of Saudi Arabia (KSA) for a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Diseases Treated

Indication Qualifiers Patient Segments
Middle East respiratory syndrome coronavirus prevention -

Subjects

  • Subject Type patients
  • Sex not stated

Trial Details

Organisations

  • Affiliations Vaccitech

Trial Dates

Other Details

  • Design prospective
  • Phase of Trial Phase I
  • Location Saudi Arabia
  • Focus Adverse reactions

Interventions

Drugs Route Formulation
Middle East respiratory syndrome coronavirus vaccine - VaccitechPrimary Drug Intramuscular
-

Middle-East-respiratory-syndrome-coronavirus-vaccine-Vaccitech

Trial History

Event Date Event Type Comment
30 Dec 2019 New trial record New trial record Updated 30 Dec 2019
20 Dec 2019 Other trial event According to Vaccitech media release, Naif Alharbi, vaccinologist is Co-PI on the Saudi MERS vaccine trial. Updated 30 Dec 2019
20 Dec 2019 Other trial event According to Vaccitech media release, trial will take place in King Abdullah International Medical Research Center (KAIMRC) and King Abdulaziz Medical City (KAMC), both are under the Ministry of National Guard Health Affairs (Saudi NGHA) Updated 30 Dec 2019

References

  1. Vaccitech. New MERS vaccine clinical trial starts in Saudi Arabia. Media-Rel 2019;.

    Media Release
Back to top